
Efavirenz Dose Reduction in HIV-1 Infected Patient Based on CYP2B6 Genotype
Purpose: | To evaluate an HIV-infected patient for CYP2B6 genotype and its effect on efavirenz dose adjustment. |
Specialty: | Toxicology Emergency Medicine Critical Care Genetics |
Objective: | dosage adjustments, adverse effects |
ICD-10: | T37.5 |
Evaluation
Results
Caution: A qualified health practitioner should verify all results.Keep patient data confidential and comply with all legal requirements.
Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited